NCT06446154
- Conditions
- Adenocarcinoma, Anti-angiogenic Therapy, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen university cancer center Guangzhou, Guangdong, China
Clinical trial condition
Immune Checkpoint Inhibitors
Explore clinical trials studying Immune Checkpoint Inhibitors. Study availability and eligibility vary by location and protocol.
27 public trials
11 recruiting studies
Immune Checkpoint Inhibitors trial results
Not Yet Recruiting
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
NCT07670715
- Conditions
- Immune Checkpoint Inhibitors, Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Neoadjuvant Chemoimmunotherapy, +1 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
Not Yet Recruiting
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
NCT07579247
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
- Locations
-
- Shanghai Public Health Clinical Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy
NCT07372079
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, China
Not Yet Recruiting
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
NCT07159217
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
- Locations
-
- Chinese Academy of Medical Sciences, Peking Union Medical College Hospital Beijing, China
Not Yet Recruiting
Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer
NCT07132008
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
Not Yet Recruiting
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
NCT06279403
- Conditions
- Clear-cell Metastatic Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma, Cytoreductive Nephrectomy, +1 more
- Locations
-
Not specified
NCT05898256
- Conditions
- Carcinoma, Head and Neck Neoplasms, Immune Checkpoint Inhibitors, +12 more
- Locations
-
Not specified
NCT07631611
- Conditions
- Brain Diseases, Brain Metastasis, Brain Neoplasms, +13 more
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
NCT06629714
- Conditions
- Biomarkers / Blood, Bronchial Neoplasms, Cancer, Treatment-Related, +18 more
- Locations
-
- Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China